IMARC Group's report titled "Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type (Sporadic ALS, Familial ALS), Drug Type (Marketed Drugs, Emerging Drugs), Diagnosis Type (Electromyo...
The immunology market is estimated to be valued at US$ 91,850 Million in 2021 and is expected to exhibit a CAGR of 8% over the forecast period 2021–2028, as highlighted in a new report published ...
SWOT Analysis:Strength: The global ALS treatment market benefits from the presence of key players with expertise in neurological disorders, such as Mitsubishi Tanabe Pharma, Takeda Pharmaceutical C...
Multiple Sclerosis Treatment Market – Segments
Acknowledging the enormous growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts...